Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 100-101

  Wang, Zhenmeng ^a   Bao, Yang ^b   Lu, Zhijie ^a   Yu, WeiFeng ^a  

^a EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

^b Jiading District Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ROCURONIUM;

ARTICLE; DRUG EFFECT; HUMAN; NEUROMUSCULAR BLOCKING; NONHUMAN; OBSTRUCTIVE JAUNDICE; PHARMACODYNAMICS;

ANDROSTANOLS; HUMANS; JAUNDICE, OBSTRUCTIVE; MODELS, THEORETICAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 78650178057     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.041     Document Type: Article

References (10)

1. Brandoni A., Villar S.R., Picena J.C., Anzai N., Endou H., Torres A.M. Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology 2006, 43(5):1092-1100.
2. McCourt K.C., Salmela L., Mirakhur R.K., et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998, 53(9):867-871.
3. -1 rocuronium in elderly and young adults with or without renal failure. Eur J Anaesthesiol 2008, 25(11):940-946.
4. Sparr H.J., Beaufort T.M., Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents?. Drugs 2001, 61(7):919-942.
5. Whalley D.G., Maurer W.G., Knapik A.L., Estafanous F.G. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia. Can J Anaesth 1998, 45(10):954-959.
6. Khuenl-Brady K., Castagnoli K.P., Canfell P.C., Caldwell J.E., Agoston S., Miller R.D. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 1990, 72(4):669-674.
7. van Miert M.M., Eastwood N.B., Boyd A.H., Parker C.J., Hunter J.M. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997, 44(2):139-144.
8. Robertson E.N., Driessen J.J., Booij L.H. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesthesiol 2005, 22(1):4-10.
9. Baillard C., Clec'h C., Catineau J., et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005, 95(5):622-626.
10. Pühringer F.K., Rex C., Sielenkämper A.W., et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008, 109(2):188-197.